Grove, Inc. Launches Amazon Aggregation Division

Upexi Unit Created to Acquire and Scale Promising Ecommerce Businesses HENDERSON, NV, Oct. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Grove, Inc. (NASDAQ:GRVI) (“Grove” or the “Company”), a global innovator in hemp, health, and wellness, today announced the launch of Upexi, its wholly owned division to acquire promising Amazon and Ecommerce businesses. Since 2020, funding has poured […]

Sphere 3D and Gryphon Secure Largest Single Hosting Services Deal in Core Scientific’s History

228 MW hosting agreement is largest in Core Scientific’s history, with an estimated capacity of 71,000 miners Toronto, Ontario–(Newsfile Corp. – October 13, 2021) – Sphere 3D Corp. (NASDAQ: ANY) (“Sphere 3D” or the “Company”), a company delivering containerization, virtualization, and data management solutions, is pleased to announce that it has entered into an agreement […]

Healthcare Triangle, Inc. Announces Pricing of $13.0 Million Initial Public Offering

PLEASANTON, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc. (“HTI” or the “Company”), a leader in the public cloud for Hospitals, Health Systems and Life Sciences today announced the pricing of its initial public offering of 3,262,500 shares of common stock (the “Common Stock”) at a public offering price of $4.00 per share, […]

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans

NEW YORK, NY October 12, 2020 / PR Newswire / Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Human Research Ethics Committee (HREC) clearance to commence cohort 2 of the Phase 1 clinical trial of BioLexa Lotion for the treatment of mild to moderate atopic dermatitis in Australia. BioLexa Trial Design: Randomized, double-blind, parallel-design, placebo-controlled […]

NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity

SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, announced today that its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 was found to be effective against SARS-CoV-2 in a standard cell culture pseudovirion assay, demonstrating that the […]

Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

— Company contracts leading global drug development company to advance initial drug candidate — MIAMI BEACH, Fla., Oct. 11, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced the initiation […]

Applied UV Continues Successful International Expansion with Installations of Airocide(R) Systems at Multiple Wineries in Mexico

Exclusive distributor has recently installed Airocide® units to help protect winemaking operations MOUNT VERNON, NY / ACCESSWIRE / October 4, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) (“Applied UV” or the “Company”), an infection control technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to […]

Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications

Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA / ACCESSWIRE / September 30, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform […]

Applied UV Announces Laboratory Results Confirm SteriLumen’s Airocide(R) Kills SARS-CoV-2 (COVID-19 Virus)

MOUNT VERNON, NY / ACCESSWIRE / September 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) (“Applied UV” or the “Company”), an infection control technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.